Parenteral Drugs (India) Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19	Mar ' 18

Sources of funds

Owner's fund

Equity share capital

29.82

29.82

29.82

29.82

29.82

Share application money

-

-

-

-

-

Preference share capital

-

13.04

13.04

13.04

13.04

Reserves & surplus

-854.17

-785.07

-663.50

-549.12

-400.96

Loan funds

Secured loans

116.03

93.20

93.20

95.67

455.41

Unsecured loans

-

-

-

-

32.59

Total

-708.32

-649.02

-527.45

-410.59

129.89

Uses of funds

Fixed assets

Gross block

205.44

785.40

785.40

785.40

785.41

Less : revaluation reserve

-

72.05

72.05

72.05

263.37

Less : accumulated depreciation

-

463.58

446.26

428.91

168.48

Net block

205.44

249.76

267.09

284.43

353.55

Capital work-in-progress

-

-

-

-

-

Investments

2.58

2.58

2.58

2.58

2.58

Net current assets

Current assets, loans & advances

274.80

242.40

208.72

180.09

144.82

Less : current liabilities & provisions

1,191.14

1,143.76

1,005.84

877.70

403.65

Total net current assets

-916.34

-901.36

-797.11

-697.60

-258.83

Miscellaneous expenses not written

-

-

-

-

-

Total

-708.32

-649.02

-527.45

-410.59

97.30

Notes:

Book value of unquoted investments

-

2.58

2.58

2.58

2.58

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

135.07

135.07

136.22

136.27

Number of equity sharesoutstanding (Lacs)

298.16

298.16

298.16

298.16

298.16